Victor Davis Hanson argues that Trump’s China trip was tactically successful, that China is an ascendant but ultimately constrained rival, and that the Iran confrontation is moving toward a decisive phase. He also says the COVID lab-leak narrative and suppression of dissent by health and intelligence bureaucracies now look increasingly confirmed, while citing California and Britain as examples of elites ignoring public anger over crime, censorship, and governance.
Watch on YouTube ›Get the market thesis, key claims, assets, contradictions, and follow-up questions from any financial video — then unlock a version personalized to your portfolio, watchlist, and favorite speakers.
This episode is a long-form conversational political and market-adjacent commentary between Jack Fowler and Victor Davis Hanson. It begins with Trump’s China trip, which Hanson calls good because Trump made no major concessions. Hanson frames Xi Jinping’s “Thucydides trap” language as provocative and historically overblown, arguing that the U.S. has faced multiple ‘ascendant powers’ before and prevailed. On China, he emphasizes structural weaknesses such as food dependence, lower fertility, and energy constraints, while saying the most immediate issues are whether China will materially aid Iran and whether it will help with the Strait of Hormuz. The discussion then shifts to Iran and the ongoing confrontation. Hanson says the conflict has already moved through a long period of haggling and that the U.S. and Israel are likely nearing a point where they will strike hard and quickly. …
Immediate setup is geopolitics-first: Iran is the key catalyst, and any hint of strikes, tanker disruption, or Chinese support would hit sentiment quickly. The near-term risk is an energy shock and headline-driven volatility, not a clean China trade narrative.
Over the next few months, the base case is continued escalation pressure on Iran and persistent uncertainty around oil flows, with China mainly relevant as a possible backer or enabler. If deterrence holds, the trade becomes less about direct war and more about a higher-risk geopolitical premium embedded in energy and defense.
The structural thesis is that U.S. power remains the anchor of the system, while China, Iran, and revisionist blocs face real internal constraints despite headline strength. Hanson’s broader regime view is a world moving back toward hard-power competition, reciprocity, and skepticism toward bureaucratic expertise.
Trump’s China trip was good because he made no comprehensive deals or concessions.
Hanson explicitly says the trip was good and stresses no concessions were made.
Xi Jinping’s Thucydides trap framing is provocative, but Hanson argues China is not in a position to overtake the U.S. easily.
He contrasts China’s structural weaknesses with repeated historical examples of failed challengers.
The most important immediate China issue is whether Beijing materially helps Iran, especially on air defense or access to the Strait of Hormuz.
He frames these as the two real issues he can fathom from the coverage.
Should I revert to democracy or at least not so much nation building?
Victor responded that what doesn't work is nation building in Afghanistan, and while it kind of worked in Iraq it came at a terrible price.
What is your take on what Donald Trump should be doing at this point now that he's back from China?
Victor thought Trump's China trip was good because he didn't make comprehensive deals or concessions. He found Xi's Thucydides Trap reference provocative. He argued that China fits the pattern of ascendant powers (like USSR, Japan, EU) that challenged the US and ultimately failed. He distilled the real issues to two: whether China will sell Iran arms (especially missile defense) and whether they'll help open the Strait, and in exchange whether the US will let Chinese tankers leave with oil. He concluded Trump's approach was pragmatic.
Did you ever know Nicole Wallace?
Victor said he knows who she is and may have seen her at a party or two, but doesn't really know her.
Unlock the full claims, asset map, scores, related transcripts, follow-up questions, and AI chat — shaped around your portfolio, watchlist, favorite speakers, and risks.
